We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

75 hedge funds and large institutions have $743M invested in C4 Therapeutics in 2020 Q4 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52.77% more ownership

Funds ownership: 0% → 52.77% (+53%)

Holders
75
Holders Change
+75
Holders Change %
–
% of All Funds
1.33%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.11%
New
75
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$91.6M
2
CAM
Cormorant Asset Management
Massachusetts
+$72.2M
3
RI
RTW Investments
New York
+$62.3M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$47.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$44.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$5.43M +$4.75M +163,771 New
IC
27
Ikarian Capital
Texas
$5.02M +$4.39M +151,500 New
SCM
28
Suvretta Capital Management
New York
$4.75M +$4.16M +143,482 New
ACM
29
Asymmetry Capital Management
California
$4.62M +$4.04M +139,343 New
Northern Trust
30
Northern Trust
Illinois
$4.14M +$3.63M +125,070 New
MS
31
Maven Securities
Jersey
$3.65M +$2.95M +101,692 New
ACP
32
Acuta Capital Partners
California
$3.64M +$3.19M +110,000 New
LCM
33
Laurion Capital Management
New York
$3.63M +$3.18M +109,600 New
Citadel Advisors
34
Citadel Advisors
Florida
$3.44M +$3.01M +103,873 New
UBS Group
35
UBS Group
Switzerland
$3.34M +$2.92M +100,716 New
Charles Schwab
36
Charles Schwab
California
$2.21M +$1.94M +66,742 New
CC
37
Casdin Capital
New York
$1.32M +$1.16M +40,000 New
Ensign Peak Advisors
38
Ensign Peak Advisors
Utah
$1.32M +$1.16M +40,000 New
PAWC
39
P.A.W. Capital
Connecticut
$1.32M +$1.16M +40,000 New
Wells Fargo
40
Wells Fargo
California
$1.28M +$1.12M +38,527 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$939K +$822K +28,341 New
N
42
Nuveen
North Carolina
$816K +$714K +24,624 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$707K +$619K +21,329 New
AAA
44
Affinity Asset Advisors
New York
$663K +$580K +20,000 New
BPC
45
Banque Pictet & Cie
Switzerland
$663K +$580K +20,000 New
Vontobel Holding
46
Vontobel Holding
Switzerland
$663K +$580K +20,000 New
ZP
47
Zimmer Partners
New York
$663K +$580K +20,000 New
CSS
48
Cubist Systematic Strategies
Connecticut
$662K +$580K +19,994 New
BFM
49
Boothbay Fund Management
New York
$537K +$470K +16,204 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$535K +$468K +16,140 New
1
2
3

CCCC Hedge Fund Activity: Q4 2020 in Review

75 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q4 2020, worth a combined $743M.

Buyers outnumbered sellers: 75 funds opened new CCCC positions and 0 closed out — a net gain of 75 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $91.6M.

  • 75 institutional investors held C4 Therapeutics (CCCC) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $743M of C4 Therapeutics stock for Q4 2020.
  • 75 funds opened new C4 Therapeutics positions in Q4 2020 and 0 closed out, a net change of +75 holders.
  • The largest C4 Therapeutics buyer in Q4 2020 was Perceptive Advisors, an estimated $91.6M added.

Based on aggregated 13F filings for Q4 2020.